BGI Genomics Co Ltd(300676)

Description: BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.

---

Keywords: Cancer Life Sciences Biology Drug Discovery Molecular Biology Food Science DNA Sequencing Severe Acute Respiratory Syndrome Related Coronavirus Exome Sequencing Laboratory Solutions

---

Home Page: www.bgi.com

Building No.7
Shenzhen, 518083
China
Phone: 86 755 2527 3120

---

Officers

Exchange: SHE

Country: CN

Currency: Renminbi (¥)